Foundation for innovation
in Cardiometabolism and Nutrition

News

  • Discovery of a new biomarker for non-invasive diagnosis of MASH: thrombospondin-2 

    Discovery of a new biomarker for non-invasive diagnosis of MASH: thrombospondin-2 

  • Heading for 2026: thank you for your commitment to our cause!

    Heading for 2026: thank you for your commitment to our cause!

  • What impact do endocrine disruptors have on metabolic liver disease? Support from the Crédit Mutuel Alliance Fédérale Foundation

    What impact do endocrine disruptors have on metabolic liver disease? Support from the Crédit Mutuel Alliance Fédérale Foundation

  • 2025 Barometer: Cardiometabolic diseases, a public health challenge that remains underestimated

    2025 Barometer: Cardiometabolic diseases, a public health challenge that remains underestimated

  • Clarivate ranking: 2 IHU ICAN researchers among the most cited in the world!

    Clarivate ranking: 2 IHU ICAN researchers among the most cited in the world!

  • Supporting research into cardiometabolism: a commitment to the health of tomorrow

    Supporting research into cardiometabolism: a commitment to the health of tomorrow

  • Symposium: Specificities and challenges of preventing cardiometabolic diseases

    Symposium: Specificities and challenges of preventing cardiometabolic diseases

  • How can AI be used to stratify the risk of rare hereditary diseases?

    How can AI be used to stratify the risk of rare hereditary diseases?

  • Physical activity: an important treatment in cardiac rehabilitation

    Physical activity: an important treatment in cardiac rehabilitation

  • The ICONIC project: creation of the 1st atlas of cardiac and hepatic imaging in the general population, including people under the age of 40

    The ICONIC project: creation of the 1st atlas of cardiac and hepatic imaging in the general population, including people under the age of 40

ISO 9001 Certified

OUr Institutionnal Supporters

Our network